Mutant proinsulin proteins associated with neonatal diabetes are retained in the endoplasmic reticulum and not

Soo-Young Park1, Honggang Ye, Donald F Steiner

  • 1Department of Medicine, The University of Chicago, 5841 S. Maryland Avenue, MC 1027, Chicago, IL 60637, USA. sooyoung@uchicago.edu

Insights

Mutations in human proinsulin cause diabetes by impairing protein secretion. Most mutant proinsulins accumulate in the endoplasmic reticulum (ER), unlike wild-type proteins, hindering insulin secretion and leading to disease.

Area of Science:

  • Molecular Endocrinology
  • Cell Biology
  • Genetics

Background:

  • Mutations in the preproinsulin protein can disrupt its processing or folding, leading to diabetes.
  • Understanding the cellular fate of these mutant proteins is crucial for elucidating disease mechanisms.

Purpose of the Study:

  • To investigate the subcellular localization and secretion of 13 neonatal diabetes-associated human proinsulin mutants.
  • To compare the behavior of these mutants with wild-type and hyperproinsulinemia-associated mutants.
  • To assess the impact of a specific mutant (C96Y) on wild-type insulin synthesis and secretion.

Main Methods:

  • Expression of 13 neonatal diabetes-associated human proinsulin mutants in rat INS-1 insulinoma cells.
  • Analysis of subcellular localization (ER vs. secretory granules) and secretion efficiency.
  • Examination of the effect of C96Y mutant proinsulin on wild-type insulin production and secretion.

Main Results:

  • Most mutant proinsulins accumulated in the endoplasmic reticulum (ER) and were poorly secreted.
  • The G84R mutant showed efficient secretion, similar to wild-type and hyperproinsulinemia mutants (H34D, R89H).
  • The C96Y mutant exhibited a dominant-negative effect, impairing wild-type insulin secretion by inducing the unfolded protein response and reducing overall translation.

Conclusions:

  • Neonatal diabetes-associated proinsulin mutations often lead to ER accumulation and impaired secretion.
  • Specific mutations can have distinct cellular trafficking and secretion profiles.
  • Mutant proinsulins can interfere with the normal processing and secretion of wild-type insulin, contributing to diabetes pathogenesis.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...